Peter-Phillip de Cruz

Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis

Patrick Hilley, Robert Gilmore, Ashish Srinivasan, Matthew Choy, Peter De Cruz

Journal article  |  2021  |  INFLAMMATORY BOWEL DISEASES

Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiological Outcomes in Crohn's Perianal Fistulas.

Michael De Gregorio, Tanya Lee, Krupa Krishnaprasad, Gregory Amos, Yoon-Kyo An, Matthew Bastian-Jordan, Jakob Begun, Nira Borok, Dougal JM Brown, Wa Cheung, Susan J Connor, Jan Gerstenmaier, Lauren E Gilbert, Robert Gilmore, Bonita Gu, Numan Kutaiba, Allan Lee, Gillian Mahy, Ashish Srinivasan, Lena Thin, et al.

Journal article  |  2021  |  Clin Gastroenterol Hepatol

BACKGROUND & AIMS: Higher anti-tumor necrosis factor-α (TNF) drug levels are associated with improved clinical healing of Crohn's ..

Accuracy of gastrointestinal ultrasound and calprotectin in the assessment of inflammation and its location in patients with an ileoanal pouch.

Zaid S Ardalan, Antony B Friedman, Danny Con, Sujievvan Chandran, David Gibson, Alan Pham, Peter De Cruz, Kwang Tay, Stephen Bell, Ourania Rosella, Miles P Sparrow, Peter R Gibson

Journal article  |  2021  |  J Crohns Colitis

BACKGROUND AND AIMS: In symptomatic patients with ileoanal pouches, pouchoscopy is needed for accurate diagnosis, but is invasive...

The reliability and accuracy of endoscopic items and scores used in the assessment of the ileoanal pouch and cuff.

Zaid S Ardalan, Danny Con, Sujievvan Chandran, Jonathan Digby-Bell, David Gibson, Alan Pham, Peter De Cruz, Kwang Tay, Stephen Bell, Miles P Sparrow, Peter R Gibson

Journal article  |  2021  |  J Crohns Colitis

BACKGROUND AND AIMS: Currently-used endoscopic items for the assessment of pouchitis and cuffitis have deficiencies in reliability..

Endoscopic Prediction of Crohn's Disease Postoperative Recurrence.

Peter De Cruz, Amy L Hamilton, Kathryn J Burrell, Alexandra Gorelik, Danny Liew, Michael A Kamm

Journal article  |  2021  |  Inflamm Bowel Dis

BACKGROUND: The presence and severity of endoscopic recurrence after Crohn's disease intestinal resection predicts subsequent dise..

Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis.

Robert Gilmore, Patrick Hilley, Ashish Srinivasan, Matthew Choy, Peter De Cruz

Journal article  |  2021  |  J Crohns Colitis

BACKGROUND AND AIMS: Preliminary data regarding the effectiveness of tofacitinib in acute severe ulcerative colitis (ASUC) have be..

Real-World Effectiveness of Ustekinumab Dose Intensification in Crohn's Disease

Ashish Srinivasan, Daniel van Langenberg, Peter De Cruz

Journal article  |  2021  |  INFLAMMATORY BOWEL DISEASES

Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis

Robert Gilmore, Patrick Hilley, Ashish Srinivasan, Matthew C Choy, Josephine A Grace, Peter De Cruz

Journal article  |  2021  |  CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

P399 Higher anti-tumour necrosis factor-alpha drug levels are associated with improved radiological outcomes in patients with perianal fistulising Crohn’s disease: A retrospective multi-centre study

M De Gregorio, T Lee, K Krishnaprasad, G Amos, YK An, M Bastian-Jordan, J Begun, N Borok, DJM Brown, W Cheung, S Connor, J Gerstenmaier, LE Gilbert, R Gilmore, B Gu, N Kutaiba, A Lee, G Mahy, A Srinivasan, L Thin, et al.

Journal article  |  2021  |  Journal of Crohn's and Colitis

Abstract Background Higher anti-tumour necrosis factor-α (TNF) drug levels are..

P302 Serum IL-6 is associated with treatment refractoriness in acute severe ulcerative colitis

C Li Wai Suen, R Morris, M Choy, J Nigro, K Visvanathan, P De Cruz

Journal article  |  2021  |  Journal of Crohn's and Colitis

Abstract Background Response to therapy in acute severe ulcerative colitis (AS..